Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Outsourcing Winners in 2014

Post recession and beyond, which contract service providers will still be standing?
Nov 2, 2010

Post recession and beyond, which contract service providers will still be standing?

Project Managers Wanted

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Sep 1, 2010

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.

Project Managers Wanted

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Aug 2, 2010

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.

Waste Not, Want Not

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Jun 9, 2010

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.

Waste Not, Want Not

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Apr 2, 2010

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.

A Bio View of Outsourcing

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.
Mar 3, 2010

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.

A Bio View of Outsourcing

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.
Feb 2, 2010

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here